SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,639.03 544.39
( 0.70%)

Global Indices

Nasdaq

53,210.99 704.96
(1.34%)

Dow Jones

7,621.51 110.79
(1.48%)

Hang Seng

63,705.00 -657.02
(-1.02%)

Nikkei 225

10,850.37 -17.68
(-0.16%)

Forex

USD-INR

95.59 -0.10
(-0.11%)

EUR-INR

109.79 0.65
(0.59%)

GBP-INR

128.11 0.75
(0.59%)

JPY-INR

0.59 0.01
(1.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2307167

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

62.02

3918.04

EPS(TTM)

Face Value()

Div & Yield %

6.3

0.03

Back

Shrenik reports standalone net profit of Rs 1.07 crore in the December 2025 quarter

Feb 11,2026

Net profit of Shrenik reported to Rs 1.07 crore in the quarter ended December 2025 as against net loss of Rs 0.07 crore during the previous quarter ended December 2024. Sales rose 97.63% to Rs 9.19 crore in the quarter ended December 2025 as against Rs 4.65 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	9.19	4.65	98
OPM %	11.64	-7.74	-
PBDT	1.07	-0.07	LP
PBT	1.07	-0.07	LP
NP	1.07	-0.07	LP

78,639.03 544.39 ( 0.70%)

53,210.99 704.96 (1.34%)

7,621.51 110.79 (1.48%)

63,705.00 -657.02 (-1.02%)

10,850.37 -17.68 (-0.16%)

95.59 -0.10 (-0.11%)

109.79 0.65 (0.59%)

128.11 0.75 (0.59%)

0.59 0.01 (1.09%)